Study of GNS561 in Patients With Liver Cancer
Clinical trial NCT03316222 · TERMINATED
Trial details
- NCT number
- NCT03316222
- Sponsor
- Genoscience Pharma
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-04
- Primary completion
- 2021-01-15
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.